Springworks Therapeutics Inc logo

SWTX

Springworks Therapeutics Inc

$39.14

Earnings Summary

Revenue
$21.01Mn
Net Profits
$-87.39Mn
Net Profit Margins
-416%

Highlights

Revenue:

Springworks Therapeutics Inc’s revenue jumped 278.01% since last year same period to $21.01Mn in the Q1 2024. On a quarterly growth basis, Springworks Therapeutics Inc has generated 285.64% jump in its revenue since last 3-months.

Net Profits:

Springworks Therapeutics Inc’s net profit fell -26.39% since last year same period to $-87.39Mn in the Q1 2024. On a quarterly growth basis, Springworks Therapeutics Inc has generated 7.35% jump in its net profits since last 3-months.

Net Profit Margins:

Springworks Therapeutics Inc’s net profit margin jumped 66.57% since last year same period to -416% in the Q1 2024. On a quarterly growth basis, Springworks Therapeutics Inc has generated 75.98% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Springworks Therapeutics Inc post its latest quarter earnings

EPS Estimate Current Quarter
-1.12
EPS Estimate Current Year
-1.12

Highlights

EPS Estimate Current Quarter:

Springworks Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -1.12 - a 4.27% jump from last quarter’s estimates.

EPS Estimate Current Year:

Springworks Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -1.12.

Key Ratios

Key ratios of the Springworks Therapeutics Inc post its Q1 2024 earnings

Earning Per Share (EPS)
-1.18
Return on Assets (ROA)
-0.37
Return on Equity (ROE)
-0.63

Highlights

Earning Per Share (EPS):

Springworks Therapeutics Inc’s earning per share (EPS) jumped 0% since last year same period to -1.18 in the Q1 2024. This indicates that the Springworks Therapeutics Inc has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Springworks Therapeutics Inc’s return on assets (ROA) stands at -0.37.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Springworks Therapeutics Inc’s return on equity (ROE) stands at -0.63.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-02
-1.17
-1.18
-0.85%